Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) EBIT Margin (2017 - 2025)

Historic EBIT Margin for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to 17.14%.

  • Inspire Medical Systems' EBIT Margin rose 38400.0% to 17.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.59%, marking a year-over-year increase of 10900.0%. This contributed to the annual value of 5.59% for FY2025, which is 10900.0% up from last year.
  • Inspire Medical Systems' EBIT Margin amounted to 17.14% in Q4 2025, which was up 38400.0% from 4.3% recorded in Q3 2025.
  • Inspire Medical Systems' 5-year EBIT Margin high stood at 17.14% for Q4 2025, and its period low was 38.88% during Q1 2021.
  • Over the past 5 years, Inspire Medical Systems' median EBIT Margin value was 5.55% (recorded in 2023), while the average stood at 6.63%.
  • As far as peak fluctuations go, Inspire Medical Systems' EBIT Margin soared by 1635700bps in 2021, and later crashed by -41300bps in 2025.
  • Over the past 5 years, Inspire Medical Systems' EBIT Margin (Quarter) stood at 2.32% in 2021, then soared by 90bps to 0.24% in 2022, then skyrocketed by 2088bps to 4.83% in 2023, then skyrocketed by 175bps to 13.3% in 2024, then grew by 29bps to 17.14% in 2025.
  • Its EBIT Margin was 17.14% in Q4 2025, compared to 4.3% in Q3 2025 and 1.53% in Q2 2025.